These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21503197)

  • 1. Vitamin D dependent rickets type I.
    Kim CJ
    Korean J Pediatr; 2011 Feb; 54(2):51-4. PubMed ID: 21503197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.
    Kitanaka S; Takeyama K; Murayama A; Sato T; Okumura K; Nogami M; Hasegawa Y; Niimi H; Yanagisawa J; Tanaka T; Kato S
    N Engl J Med; 1998 Mar; 338(10):653-61. PubMed ID: 9486994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.
    Panda DK; Miao D; Tremblay ML; Sirois J; Farookhi R; Hendy GN; Goltzman D
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7498-503. PubMed ID: 11416220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus.
    St-Arnaud R; Messerlian S; Moir JM; Omdahl JL; Glorieux FH
    J Bone Miner Res; 1997 Oct; 12(10):1552-9. PubMed ID: 9333115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal 24-hydroxylation of vitamin D metabolites in patients with vitamin D-dependency rickets type I. Structural implications for the vitamin D hydroxylases.
    Mandla S; Jones G; Tenenhouse HS
    J Clin Endocrinol Metab; 1992 Apr; 74(4):814-20. PubMed ID: 1548347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of vitamin D3 by cytochromes P450.
    Sakaki T; Kagawa N; Yamamoto K; Inouye K
    Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets.
    Dardenne O; Prud'homme J; Arabian A; Glorieux FH; St-Arnaud R
    Endocrinology; 2001 Jul; 142(7):3135-41. PubMed ID: 11416036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-dependent rickets type I and type II.
    Takeda E; Yamamoto H; Taketani Y; Miyamoto K
    Acta Paediatr Jpn; 1997 Aug; 39(4):508-13. PubMed ID: 9316302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic disorders of Vitamin D biosynthesis and degradation.
    Miller WL
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):101-108. PubMed ID: 27060335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase.
    Zehnder D; Hewison M
    Mol Cell Endocrinol; 1999 May; 151(1-2):213-20. PubMed ID: 10411336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
    Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
    J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutation in the human 25-hydroxyvitamin D3 1alpha-hydroxylase gene causes vitamin D-dependent rickets type I.
    Kato S
    Mol Cell Endocrinol; 1999 Oct; 156(1-2):7-12. PubMed ID: 10612418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Hydroxylation-deficient Rickets Type 1A Misdiagnosed as Normocalcemic Primary Hyperparathyroidism.
    Rivero-García P; Aguilar-Lugo-Gerez JJ; Kimball TN; Reza-Albarrán AA
    JCEM Case Rep; 2023 Jul; 1(4):luad084. PubMed ID: 37908980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?
    Molin A; Wiedemann A; Demers N; Kaufmann M; Do Cao J; Mainard L; Dousset B; Journeau P; Abeguile G; Coudray N; Mittre H; Richard N; Weryha G; Sorlin A; Jones G; Kottler ML; Feillet F
    J Bone Miner Res; 2017 Sep; 32(9):1893-1899. PubMed ID: 28548312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo function of VDR in gene expression-VDR knock-out mice.
    Kato S; Takeyama K; Kitanaka S; Murayama A; Sekine K; Yoshizawa T
    J Steroid Biochem Mol Biol; 1999; 69(1-6):247-51. PubMed ID: 10418998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.
    Vanhooke JL; Prahl JM; Kimmel-Jehan C; Mendelsohn M; Danielson EW; Healy KD; DeLuca HF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):75-80. PubMed ID: 16371465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation update and long-term outcome after treatment with active vitamin D
    Chi Y; Sun J; Pang L; Jiajue R; Jiang Y; Wang O; Li M; Xing X; Hu Y; Zhou X; Meng X; Xia W
    Osteoporos Int; 2019 Feb; 30(2):481-489. PubMed ID: 30382318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human 25-hydroxyvitamin D-1alpha-hydroxylase: cloning, mutations, and gene expression.
    Portale AA; Miller WL
    Pediatr Nephrol; 2000 Jul; 14(7):620-5. PubMed ID: 10912530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.